M. Bondy, M. Scheurer, B. Malmer, J. Barnholtz-sloan, F. Davis et al., Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium, Cancer, vol.16, issue.2-3, pp.1953-68, 2008.
DOI : 10.1002/cncr.23741

L. Muldoon, C. Soussain, K. Jahnke, C. Johanson, T. Siegal et al., Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check, Journal of Clinical Oncology, vol.25, issue.16, pp.2295-305, 2007.
DOI : 10.1200/JCO.2006.09.9861

T. Schumacher, S. Hofer, K. Eichhorn, M. Wasner, S. Zimmerer et al., Local injection of the 90Y-labelled peptidic vector DOTATOC to control gliomas of WHO grades II and III: an extended pilot study, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.4, pp.486-93, 2002.
DOI : 10.1007/s00259-001-0717-x

D. Reardon, J. Quinn, G. Akabani, R. Coleman, A. Friedman et al., Novel human IgG2b/murine chimeric antitenascin monoclonal antibody construct radiolabeled with 131I and administered into the surgically created resection cavity of patients with malignant glioma: phase I trial results, J Nucl Med, vol.47, pp.912-920, 2006.

A. Casaco, G. Lopez, I. Garcia, J. Rodriguez, R. Fernandez et al., Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma, Cancer Biology & Therapy, vol.7, issue.3, pp.333-342, 2008.
DOI : 10.4161/cbt.7.3.5414

S. Caruthers, S. Wickline, and G. Lanza, Nanotechnological applications in medicine, Current Opinion in Biotechnology, vol.18, issue.1, pp.26-30, 2007.
DOI : 10.1016/j.copbio.2007.01.006

B. Heurtault, P. Saulnier, B. Pech, J. Proust, and J. Benoit, A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-80, 2002.
DOI : 10.1023/A:1016121319668

E. Allard, F. Hindre, C. Passirani, L. Lemaire, N. Lepareur et al., 188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas, European Journal of Nuclear Medicine and Molecular Imaging, vol.112, issue.10, pp.1838-1884, 2008.
DOI : 10.1007/s00259-008-0735-z

URL : https://hal.archives-ouvertes.fr/inserm-00343438

J. Hureaux, F. Lagarce, F. Gagnadoux, L. Vecellio, A. Clavreul et al., Lipid nanocapsules: Ready-to-use nanovectors for the aerosol delivery of paclitaxel, European Journal of Pharmaceutics and Biopharmaceutics, vol.73, issue.2, pp.239-285, 2009.
DOI : 10.1016/j.ejpb.2009.06.013

A. Vonarbourg, C. Passirani, L. Desigaux, E. Allard, P. Saulnier et al., The encapsulation of DNA molecules within biomimetic lipid nanocapsules, Biomaterials, vol.30, issue.18, pp.3197-204, 2009.
DOI : 10.1016/j.biomaterials.2009.03.009

E. Garcion, A. Lamprecht, B. Heurtault, A. Paillard, A. Aubert-pouessel et al., A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Molecular Cancer Therapeutics, vol.5, issue.7, pp.1710-1732, 2006.
DOI : 10.1158/1535-7163.MCT-06-0289

URL : https://hal.archives-ouvertes.fr/hal-00358958

A. Lamprecht and J. Benoit, Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition, Journal of Controlled Release, vol.112, issue.2, pp.208-221, 2006.
DOI : 10.1016/j.jconrel.2006.02.014

E. Roger, F. Lagarce, E. Garcion, and J. Benoit, Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells, European Journal of Pharmaceutical Sciences, vol.40, issue.5, pp.422-431, 2010.
DOI : 10.1016/j.ejps.2010.04.015

A. Paillard, F. Hindre, C. Vignes-colombeix, J. Benoit, and E. Garcion, The importance of endo-lysosomal escape with lipid nanocapsules for drug subcellular bioavailability, Biomaterials, vol.31, issue.29, pp.7542-54, 2010.
DOI : 10.1016/j.biomaterials.2010.06.024

S. Vinchon-petit, D. Jarnet, A. Paillard, J. Benoit, E. Garcion et al., In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy, Journal of Neuro-Oncology, vol.28, issue.2, pp.195-205
DOI : 10.1007/s11060-009-0012-4

B. Bucci, S. Misiti, A. Cannizzaro, R. Marchese, G. Raza et al., Fractionated ionizing radiation exposure induces apoptosis through caspase-3 activation and reactive oxygen species generation, Anticancer Res, vol.26, pp.4549-57, 2006.

G. Guo, Y. Yan-sanders, B. Lyn-cook, T. Wang, D. Tamae et al., Manganese Superoxide Dismutase-Mediated Gene Expression in Radiation-Induced Adaptive Responses, Molecular and Cellular Biology, vol.23, issue.7
DOI : 10.1128/MCB.23.7.2362-2378.2003

L. Apetoh, F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz et al., Toll-like receptor 4???dependent contribution of the immune system to anticancer chemotherapy and radiotherapy, Nature Medicine, vol.289, issue.9, pp.1050-1059, 2007.
DOI : 10.1038/nm1622

URL : https://hal.archives-ouvertes.fr/hal-00316924

P. Coates, J. Rundle, S. Lorimore, and E. Wright, Indirect Macrophage Responses to Ionizing Radiation: Implications for Genotype-Dependent Bystander Signaling, Cancer Research, vol.68, issue.2, pp.450-456, 2008.
DOI : 10.1158/0008-5472.CAN-07-3050

S. Formenti and S. Demaria, Systemic effects of local radiotherapy, The Lancet Oncology, vol.10, issue.7, pp.718-744, 2009.
DOI : 10.1016/S1470-2045(09)70082-8

L. Galluzzi, M. Maiuri, I. Vitale, H. Zischka, M. Castedo et al., Cell death modalities: classification and pathophysiological implications, Cell Death and Differentiation, vol.94, issue.7, pp.1237-1280, 2007.
DOI : 10.1038/sj.cdd.4402148

M. Larsson, J. Fonteneau, and N. Bhardwaj, Dendritic cells resurrect antigens from dead cells, Trends in Immunology, vol.22, issue.3
DOI : 10.1016/S1471-4906(01)01860-9

F. Pasi, A. Facoetti, and R. Nano, IL-8 and IL-6 bystander signalling in human glioblastoma cells exposed to gamma radiation, Anticancer Res, vol.30, pp.2769-72, 2010.

D. Hallahan, D. Spriggs, M. Beckett, D. Kufe, and R. Weichselbaum, Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation., Proceedings of the National Academy of Sciences, vol.86, issue.24, pp.10104-10111, 1989.
DOI : 10.1073/pnas.86.24.10104

J. Hong, C. Chiang, C. Tsao, P. Lin, W. Mcbride et al., Rapid induction of cytokine gene expression in the lung after single and fractionated doses of radiation, Int J Radiat Biol, vol.75, pp.1421-1428, 1999.

R. Roses, M. Xu, G. Koski, and B. Czerniecki, Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer, Oncogene, vol.171, issue.2, pp.200-207, 2008.
DOI : 10.1084/jem.20062056

N. Bennewitz and J. Babensee, The effect of the physical form of poly(lactic-co-glycolic acid) carriers on the humoral immune response to co-delivered antigen, Biomaterials, vol.26, issue.16, pp.2991-3000, 2005.
DOI : 10.1016/j.biomaterials.2004.08.023

R. Hunter, F. Strickland, and F. Kezdy, The adjuvant activity of nonionic block polymer surfactants. I. The role of hydrophile-lipophile balance, J Immunol, vol.127, pp.1244-50, 1981.

S. Reddy, M. Swartz, and J. Hubbell, Targeting dendritic cells with biomaterials: developing the next generation of vaccines, Trends in Immunology, vol.27, issue.12, pp.573-582, 2006.
DOI : 10.1016/j.it.2006.10.005

M. Yoshida and J. Babensee, Poly(lactic-co-glycolic acid) enhances maturation of human monocyte-derived dendritic cells, Journal of Biomedical Materials Research, vol.2, issue.1, pp.45-54, 2004.
DOI : 10.1002/jbm.a.30131

N. Lepareur and . Nnahj, A kit formulation for the labelling of lipiodol with generator-produced188Re, Journal of Labelled Compounds and Radiopharmaceuticals, vol.9, issue.12, pp.857-67, 2004.
DOI : 10.1002/jlcr.863

S. Vinchon-petit, D. Jarnet, E. Jadaud, L. Feuvret, E. Garcion et al., External irradiation models for intracranial 9L glioma studies, Journal of Experimental & Clinical Cancer Research, vol.29, issue.1, p.142, 2010.
DOI : 10.1186/1756-9966-29-142

V. Recinos, B. Tyler, K. Bekelis, S. Sunshine, A. Vellimana et al., Combination of Intracranial Temozolomide With Intracranial Carmustine Improves Survival When Compared With Either Treatment Alone in a Rodent Glioma Model, Neurosurgery, vol.66, issue.3, pp.530-537, 2010.
DOI : 10.1227/01.NEU.0000365263.14725.39

L. Brady, C. Miyamoto, D. Woo, M. Rackover, J. Emrich et al., Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: A phase II trial, International Journal of Radiation Oncology*Biology*Physics, vol.22, issue.1, pp.225-255, 1992.
DOI : 10.1016/0360-3016(92)91009-C

W. Roth and M. Weller, Chemotherapy and immunotherapy of malignant glioma: molecular mechanisms and clinical perspectives, Cellular and Molecular Life Sciences (CMLS), vol.56, issue.5-6, pp.481-506, 1999.
DOI : 10.1007/s000180050447

R. Bhat and L. Steinman, Innate and Adaptive Autoimmunity Directed to the Central Nervous System, Neuron, vol.64, issue.1, pp.123-155, 2009.
DOI : 10.1016/j.neuron.2009.09.015

P. Carpentier and T. Palmer, Immune Influence on Adult Neural Stem Cell Regulation and Function, Neuron, vol.64, issue.1, pp.79-92, 2009.
DOI : 10.1016/j.neuron.2009.08.038

J. Adams and A. Strasser, Is Tumor Growth Sustained by Rare Cancer Stem Cells or Dominant Clones?, Cancer Research, vol.68, issue.11, pp.4018-4039, 2008.
DOI : 10.1158/0008-5472.CAN-07-6334

S. Bao, Q. Wu, R. Mclendon, Y. Hao, Q. Shi et al., Glioma stem cells promote radioresistance by preferential activation of the DNA damage response, Nature, vol.8, issue.7120, pp.756-60, 2006.
DOI : 10.1038/nature05236

J. Rich, Cancer Stem Cells in Radiation Resistance, Cancer Research, vol.67, issue.19, pp.8980-8984, 2007.
DOI : 10.1158/0008-5472.CAN-07-0895

M. Obeid, T. Panaretakis, N. Joza, R. Tufi, A. Tesniere et al., Calreticulin exposure is required for the immunogenicity of ??-irradiation and UVC light-induced apoptosis, Cell Death and Differentiation, vol.59, issue.10, pp.1848-50, 2007.
DOI : 10.1016/S0022-1759(02)00069-8

M. Obeid, A. Tesniere, F. Ghiringhelli, G. Fimia, L. Apetoh et al., Calreticulin exposure dictates the immunogenicity of cancer cell death, Nature Medicine, vol.279, issue.1, pp.54-61, 2007.
DOI : 10.1038/nm1523

URL : https://hal.archives-ouvertes.fr/inserm-00451702

M. Chakraborty, S. Abrams, C. Coleman, K. Camphausen, J. Schlom et al., External Beam Radiation of Tumors Alters Phenotype of Tumor Cells to Render Them Susceptible to Vaccine-Mediated T-Cell Killing, Cancer Research, vol.64, issue.12, pp.4328-4365, 2004.
DOI : 10.1158/0008-5472.CAN-04-0073

S. Demaria, E. Pikarsky, M. Karin, L. Coussens, Y. Chen et al., Cancer and Inflammation: Promise for Biologic Therapy, Journal of Immunotherapy, vol.33, issue.4, pp.335-51, 2010.
DOI : 10.1097/CJI.0b013e3181d32e74

M. Izquierdo, J. Neefjes, A. Mathari, M. Flens, G. Scheffer et al., Overexpression of the ABC transporter TAP in multidrug-resistant human cancer cell lines, British Journal of Cancer, vol.74, issue.12, pp.1961-1968, 1996.
DOI : 10.1038/bjc.1996.660

P. Manavalan, A. Smith, and J. Mcpherson, Sequence and structural homology among membrane-associated domains of CFTR and certain transporter proteins, Journal of Protein Chemistry, vol.266, issue.3, pp.279-90, 1993.
DOI : 10.1007/BF01028190

F. Lefranc and R. Kiss, Autophagy, the Trojan horse to combat glioblastomas, Neurosurgical Focus, vol.20, issue.4, pp.7-30, 2006.
DOI : 10.3171/foc.2006.20.4.4